What's happening in the pharmaceutical industry right now, and how are leading companies tackling the challenge? This report from LogiPharma 2023 includes contributions from 13 experts, including Merck, Johnson & Johnson, and One Network Enterprises.
Some of the LogiPharma Survey findings include:
- End-to-end supply chain visibility remains a top challenge and priority for most pharmaceutical companies
- Work on operational resilience and quality assurance is paying off
- Half of respondents visibility and data modelling are top priorities for supporting the digital supply chain journey
Recommendations include Using Digital Innovation for Continuous Supply Chain Management Improvement - how companies can rapidly transform, digitize their supply networks, and see a quick return, while enhancing their agility and resilience to future supply chain shocks.
Read Now